載入...

Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy

5-Aza-2′-deoxycytidine (5-AZA-CdR, decitabine), an epigenetic drug that inhibits DNA methylation, is currently used to treat myelodysplastic syndrome (MDS), and is under investigation for treating acute myeloid leukemia (AML) and other malignancies. 5-AZA-CdR can reactivate tumor suppressor genes si...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Karahoca, Metin, Momparler, Richard L
格式: Artigo
語言:Inglês
出版: BioMed Central 2013
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570332/
https://ncbi.nlm.nih.gov/pubmed/23369223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1868-7083-5-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!